Annual Total Liabilities
$95.52 M
+$49.30 M+106.67%
December 31, 2021
Summary
- As of February 10, 2025, MITO annual total liabilities is $95.52 million, with the most recent change of +$49.30 million (+106.67%) on December 31, 2021.
- During the last 3 years, MITO annual total liabilities has fallen by -$306.71 million (-76.25%).
Performance
MITO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$89.23 M
-$6.29 M-6.58%
March 31, 2022
Summary
- As of February 10, 2025, MITO quarterly total liabilities is $89.23 million, with the most recent change of -$6.29 million (-6.58%) on March 31, 2022.
- Over the past year, MITO quarterly total liabilities has increased by +$42.37 million (+90.42%).
Performance
MITO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MITO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +106.7% | +90.4% |
| 3 y3 years | -76.3% | +129.2% |
| 5 y5 years | -68.0% | -70.1% |
MITO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -6.6% | at low |
| 5 y | 5-year | at high | -62.9% | -6.6% | -77.3% |
| alltime | all time | -76.3% | -62.9% | -77.8% | -77.3% |
Stealth BioTherapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $89.23 M(-6.6%) |
| Dec 2021 | $95.52 M(+106.7%) | $95.52 M(+30.8%) |
| Sep 2021 | - | $73.02 M(+24.7%) |
| Jun 2021 | - | $58.57 M(+25.0%) |
| Mar 2021 | - | $46.86 M(+1.4%) |
| Dec 2020 | $46.22 M | $46.22 M(+128.2%) |
| Sep 2020 | - | $20.25 M(-8.3%) |
| Jun 2020 | - | $22.09 M(-25.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $29.72 M(-16.2%) |
| Dec 2019 | $35.48 M(-91.2%) | $35.48 M(-1.2%) |
| Sep 2019 | - | $35.89 M(-0.3%) |
| Jun 2019 | - | $36.01 M(-7.5%) |
| Mar 2019 | - | $38.94 M(-90.3%) |
| Dec 2018 | $402.23 M(+34.8%) | $402.23 M(+803.5%) |
| Sep 2018 | - | $44.52 M(-85.1%) |
| Dec 2017 | $298.44 M(+33.7%) | $298.44 M |
| Dec 2016 | $223.15 M | - |
FAQ
- What is Stealth BioTherapeutics annual total liabilities?
- What is the all time high annual total liabilities for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics annual total liabilities year-on-year change?
- What is Stealth BioTherapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics quarterly total liabilities year-on-year change?
What is Stealth BioTherapeutics annual total liabilities?
The current annual total liabilities of MITO is $95.52 M
What is the all time high annual total liabilities for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high annual total liabilities is $402.23 M
What is Stealth BioTherapeutics annual total liabilities year-on-year change?
Over the past year, MITO annual total liabilities has changed by +$49.30 M (+106.67%)
What is Stealth BioTherapeutics quarterly total liabilities?
The current quarterly total liabilities of MITO is $89.23 M
What is the all time high quarterly total liabilities for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high quarterly total liabilities is $402.23 M
What is Stealth BioTherapeutics quarterly total liabilities year-on-year change?
Over the past year, MITO quarterly total liabilities has changed by +$42.37 M (+90.42%)